Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 108
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

CLINICAL STUDY

The risk factors for cytomegalovirus reactivation following stem cell transplantation

Valadkhani Bahareh, Kargar Mona, Ashouri Asieh, Hadjibabaie Molouk, Gholami Kheirollah, Ghavamzadeh Ardeshir

Year : 2016| Volume: 5| Issue : 1 | Page no: 63-69

   This article has been cited by
 
1 New Developments in the Management of Cytomegalovirus Infection After Transplantation
Atibordee Meesing,Raymund R. Razonable
Drugs. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation
Brandon J. Webb,Rachel Harrington,Jason Schwartz,Jennifer Kammerer,James Spalding,Edward Lee,Bart Dodds,Stephanie Kaufusi,Bruce E. Goodman,Sean D. Firth,Greta Martin,Jeffrey Sorensen,Daanish Hoda
Transplant Infectious Disease. 2018; : e12961
[Pubmed]  [Google Scholar] [DOI]
3 Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem
N Berman,H M Belmont
Lupus. 2017; 26(4): 431
[Pubmed]  [Google Scholar] [DOI]
4 Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R. McCurdy,Christopher G. Kanakry,Hua-Ling Tsai,Yvette L. Kasamon,Margaret M. Showel,Javier Bolaños-Meade,Carol Ann Huff,Ivan Borrello,William H. Matsui,Robert A. Brodsky,Richard F. Ambinder,Maria P. Bettinotti,Ephraim J. Fuchs,Gary L. Rosner,Richard J. Jones,Leo Luznik
Biology of Blood and Marrow Transplantation. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article